4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000111
Options or other derivatives
- Chief Medical Officer acquired 25,124 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-01 | Grant or award : show line 1 in the form Restricted stock units | +25,124 | 25,124 | D |
Loading xslF345X04/wk-form4_1688673850.xml…